Literature DB >> 22238161

Oral transmission of Chagas disease.

Maria Aparecida Shikanai-Yasuda1, Noemia Barbosa Carvalho.   

Abstract

Chagas disease is now an active disease in the urban centers of countries of nonendemicity and endemicity because of congenital and blood and/or organ transplantation transmissions and the reactivation of the chronic disease in smaller scale than vectorial transmission, reported as controlled in countries of endemicity. Oral transmission of Chagas disease has emerged in unpredictable situations in the Amazon region and, more rarely, in areas of nonendemicity where the domiciliary triatomine cycle was under control because of exposition of the food to infected triatomine and contaminated secretions of reservoir hosts. Oral transmission of Chagas disease is considered when >1 acute case of febrile disease without other causes is linked to a suspected food and should be confirmed by the presence of the parasite after direct microscopic examination of the blood or other biological fluid sample from the patient.

Entities:  

Mesh:

Year:  2012        PMID: 22238161     DOI: 10.1093/cid/cir956

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  104 in total

Review 1.  Chagas disease and transfusion medicine: a perspective from non-endemic countries.

Authors:  Andrea Angheben; Lucia Boix; Dora Buonfrate; Federico Gobbi; Zeno Bisoffi; Simonetta Pupella; Giorgio Gandini; Giuseppe Aprili
Journal:  Blood Transfus       Date:  2015-10       Impact factor: 3.443

Review 2.  Transmission and epidemiology of zoonotic protozoal diseases of companion animals.

Authors:  Kevin J Esch; Christine A Petersen
Journal:  Clin Microbiol Rev       Date:  2013-01       Impact factor: 26.132

3.  Characterization of Trypanosoma cruzi infectivity, proliferation, and cytokine patterns in gut and pancreatic epithelial cells maintained in vitro.

Authors:  Laura A Martello; Raj Wadgaonkar; Raavi Gupta; Fabiana S Machado; Michael G Walsh; Eduardo Mascareno; Herbert B Tanowitz; M A Haseeb
Journal:  Parasitol Res       Date:  2013-09-10       Impact factor: 2.289

Review 4.  Chagas Disease in the United States: a Public Health Approach.

Authors:  Caryn Bern; Louisa A Messenger; Jeffrey D Whitman; James H Maguire
Journal:  Clin Microbiol Rev       Date:  2019-11-27       Impact factor: 26.132

5.  Prevalence of Trypanosoma cruzi and Other Trypanosomatids in Frequently-Hunted Wild Mammals from the Peruvian Amazon.

Authors:  E Angelo Morales; Pedro Mayor; Mark Bowler; Esar Aysanoa; Erika S Pérez-Velez; Jocelyn Pérez; Julio A Ventocilla; G Christian Baldeviano; Andrés G Lescano
Journal:  Am J Trop Med Hyg       Date:  2017-11       Impact factor: 2.345

6.  Diet regulates liver autophagy differentially in murine acute Trypanosoma cruzi infection.

Authors:  Kezia Lizardo; Vanessa Almonte; Calvin Law; Janeesh Plakkal Aiyyappan; Min-Hui Cui; Jyothi F Nagajyothi
Journal:  Parasitol Res       Date:  2016-12-16       Impact factor: 2.289

7.  Immunopathologic characterization of naturally acquired Trypanosoma cruzi infection and cardiac sequalae in cynomolgus macaques (Macaca fascicularis).

Authors:  Harshan Pisharath; Chih-Ling Zao; John Kreeger; Susan Portugal; Thomas Kawabe; Tarea Burton; Lisa Tomaeck; Ahmed Shoieb; Brandy Morenko Campbell; Judy Franco
Journal:  J Am Assoc Lab Anim Sci       Date:  2013-09       Impact factor: 1.232

Review 8.  Pathology and Pathogenesis of Chagas Heart Disease.

Authors:  Kevin M Bonney; Daniel J Luthringer; Stacey A Kim; Nisha J Garg; David M Engman
Journal:  Annu Rev Pathol       Date:  2018-10-24       Impact factor: 23.472

Review 9.  Diagnosis and management of Chagas disease and cardiomyopathy.

Authors:  Antonio L Ribeiro; Maria P Nunes; Mauro M Teixeira; Manoel O C Rocha
Journal:  Nat Rev Cardiol       Date:  2012-07-31       Impact factor: 32.419

Review 10.  Current understanding of immunity to Trypanosoma cruzi infection and pathogenesis of Chagas disease.

Authors:  Fabiana S Machado; Walderez O Dutra; Lisia Esper; Kenneth J Gollob; Mauro M Teixeira; Stephen M Factor; Louis M Weiss; Fnu Nagajyothi; Herbert B Tanowitz; Nisha J Garg
Journal:  Semin Immunopathol       Date:  2012-10-18       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.